Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)

Capecitabine and temozolomide (CAPTEM) have shown promising results in the treatment of neuroendocrine neoplasms (NEN). The aim of this study was to evaluate the outcome and role for CAPTEM in malignant neuroendocrine neoplasms. Data were obtained from NEN patients who received at least one cycle of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Thomas, Katharine, Voros, Brianne A., Meadows-Taylor, Meghan, Smeltzer, Matthew P., Griffin, Ryan, Boudreaux, J. Philip, Thiagarajan, Ramcharan, Woltering, Eugene A., Ramirez, Robert A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017154/
https://ncbi.nlm.nih.gov/pubmed/31947598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010206
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk